RYTM Earnings

Quarterly EPS
$-0.73
Q3 2024
$-0.72
Q4 2024
$-0.81
Q1 2025
$-0.75
Q2 2025
$-0.82
Q3 2025
$-0.73
Q4 2025
$-0.83
Q1 2026
$-0.73
Q2 2026
Latest Revenue71.3M
Latest Net Income-49298000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.7371.3M-49298000+46.9%+2.7%
Q1 2026-$0.8360.1M-55639000+83.8%-2.5%
Q4 2025-$0.7357.3M-47505000+36.9%-1.4%
Q3 2025-$0.8251.3M-52904000+54.3%-12.3%
Q2 2025-$0.7548.5M-46632000+66.8%-36.4%
Q1 2025-$0.8132.7M-49498000+25.9%+65.5%
Q4 2024-$0.7241.8M-43292000+72.6%-2.9%
Q3 2024-$0.7333.3M-43641000+47.8%+3.9%
Q2 2024-$0.5529.1M-32261000
Q1 2024-$2.3526.0M-141372000
Q4 2023-$0.7024.2M-41633000
Q3 2023-$0.7622.5M-44163000
Rhythm Pharmaceuticals (RYTM) — Earnings